FENC
Fennec Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.39
−1.27%0
Insider buys (3m)
5
Insider sells (3m)
-$1.3M
Net value (3m)
+43.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Raykov Rosty · other: Former Director | A-Award | 2,778 | $0.00 |
| Sep 1, 2026 | Raykov Rosty · other: Former Director | Sale | 10,000 | $12 |
| Aug 31, 2026 | Evans Terry L · officer: Chief Commercial Officer | A-Award | 168 | $0.00 |
| Aug 31, 2026 | Sayad Pierre Sargis · officer: Chief Medical Officer | Sale | 12,000 | $12 |
| Aug 31, 2026 | Cioffi Christiana Marie · officer: Chief Strategy Officer | A-Award | 156 | $0.00 |
| Aug 31, 2026 | Hackman Jeffrey S. · director, officer: Chief Executive Officer | A-Award | 1,159 | $0.00 |
| Aug 31, 2026 | Andrade Robert · officer: CHIEF FINANCIAL OFFICER | A-Award | 1,703 | $0.00 |
| Aug 31, 2026 | Sayad Pierre Sargis · officer: Chief Medical Officer | A-Award | 168 | $0.00 |
| Aug 28, 2026 | Andrade Robert · officer: CHIEF FINANCIAL OFFICER | Sale | 75,000 | $12 |
| Aug 28, 2026 | Andrade Robert · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 21,928 | $5.10 |
| Aug 4, 2026 | Raykov Rosty · other: Former Director | Sale | 10,000 | $9.58 |
| Aug 3, 2026 | Cioffi Christiana Marie · officer: Chief Strategy Officer | A-Award | 156 | $0.00 |
| Aug 3, 2026 | Hackman Jeffrey S. · director, officer: Chief Executive Officer | A-Award | 1,159 | $0.00 |
| Aug 3, 2026 | Raykov Rosty · other: Former Director | A-Award | 2,778 | $0.00 |
| Aug 3, 2026 | Evans Terry L · officer: Chief Commercial Officer | A-Award | 168 | $0.00 |
| Aug 3, 2026 | Sayad Pierre Sargis · officer: Chief Medical Officer | A-Award | 168 | $0.00 |
| Aug 3, 2026 | Andrade Robert · officer: CHIEF FINANCIAL OFFICER | A-Award | 1,703 | $0.00 |
| Jul 2, 2026 | Raykov Rosty · other: Former Director | A-Award | 2,778 | $0.00 |
| Jul 2, 2026 | Raykov Rosty · other: Former Director | M-Exempt | 15,597 | $2.45 |
| Jul 2, 2026 | Raykov Rosty · other: Former Director | Sale | 9,599 | $10 |
| Jul 1, 2026 | Evans Terry L · officer: Chief Commercial Officer | A-Award | 168 | $0.00 |
| Jul 1, 2026 | Sayad Pierre Sargis · officer: Chief Medical Officer | A-Award | 168 | $0.00 |
| Jul 1, 2026 | Cioffi Christiana Marie · officer: Chief Strategy Officer | A-Award | 156 | $0.00 |
| Jul 1, 2026 | Andrade Robert · officer: CHIEF FINANCIAL OFFICER | A-Award | 1,703 | $0.00 |
| Jul 1, 2026 | Hackman Jeffrey S. · director, officer: Chief Executive Officer | A-Award | 1,159 | $0.00 |
| Jun 10, 2026 | Brughera Marco Maria · director | A-Award | 20,000 | $8.70 |
| Jun 10, 2026 | Cook Jodi A · director | A-Award | 20,000 | $8.70 |
| Jun 10, 2026 | Islam Khalid · director | A-Award | 25,000 | $8.70 |
| Jun 10, 2026 | RALLIS CHRIS A · director | A-Award | 20,000 | $8.70 |
| Jun 2, 2026 | Raykov Rosty · director | A-Award | 2,778 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 43Increased 83Reduced 37Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Rosalind Advisors, Inc. | Increased | 3,188,001 | Aug 14, 2026 |
| ROSALIND ADVISORS, INC. | Increased | 2,908,201 | May 14, 2026 |
| SOUTHPOINT CAPITAL ADVISORS LP | Unchanged | 2,744,741 | May 15, 2026 |
| AIGH Capital Management LLC | Increased | 2,486,038 | Aug 7, 2026 |
| SOLAS CAPITAL MANAGEMENT, LLC | Reduced | 2,482,198 | May 15, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Increased | 1,981,501 | Apr 30, 2026 |
| Solas Capital Management, LLC | Reduced | 1,889,366 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 1,727,069 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 1,368,176 | May 13, 2026 |
| AWM Investment Company, Inc. | Increased | 1,160,296 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 897,144 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 839,306 | Aug 13, 2026 |
| AWM INVESTMENT COMPANY, INC. | Increased | 720,135 | May 15, 2026 |
| Prospect Capital Advisors, LLC | New Position | 497,800 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 426,004 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026